Gossamer Bio Inc [GOSS] stock prices are up 2.94% to $1.75 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The GOSS shares have gain 14.38% over the last week, with a monthly amount glided 35.66%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Gossamer Bio Inc [NASDAQ: GOSS] stock has seen the most recent analyst activity on July 14, 2025, when Scotiabank initiated its Sector Outperform rating and assigned the stock a price target of $11. Previously, Oppenheimer started tracking the stock with Outperform rating on June 25, 2024, and set its price target to $9. UBS downgraded its rating to a Neutral and decreased its price target to $1.25 on July 27, 2023. Raymond James downgraded its rating to a Mkt Perform. In a note dated December 07, 2022, SMBC Nikko downgraded an Neutral rating on this stock but restated the target price of $3.
The stock price of Gossamer Bio Inc [GOSS] has been fluctuating between $0.66 and $1.90 over the past year. Currently, Wall Street analysts expect the stock to reach $3.75 within the next 12 months. Gossamer Bio Inc [NASDAQ: GOSS] shares were valued at $1.75 at the most recent close of the market. An investor can expect a potential return of 114.29% based on the average GOSS price forecast.
Analyzing the GOSS fundamentals
Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -0.44%, Pretax Profit Margin comes in at -0.4%, and Net Profit Margin reading is -0.41%. To continue investigating profitability, this company’s Return on Assets is posted at -0.18, Equity is -1.29 and Total Capital is -0.24. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -32.31.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Gossamer Bio Inc [NASDAQ:GOSS]’s Current Ratio is 5.71. In addition, the Quick Ratio stands at 5.71 and the Cash Ratio stands at 0.6. Considering the valuation of this stock, the price to sales ratio is 3.19.
